P21 is a synthetic hexapeptide derived from the active fragment of CNTF and modified with an adamantane group. It is studied for its effect on endogenous CNTF and BDNF signalling in hippocampal neurogenesis research.
- Synthetic hexapeptide (Ac-DGGLAG-NH2) with adamantane modification
- Derived from the CNTF active fragment (residues 147 to 150)
- Identified via epitope mapping of Cerebrolysin peptides
- Amplifies endogenous CNTF and BDNF signalling pathways
- Studied in hippocampal neurogenesis and cognitive research
Research profile: P21: structure, mechanism and research use





